FIGS, Inc. filings document the company’s healthcare apparel business, operating results and public-company governance. Form 8-K reports furnish earnings releases and Regulation FD presentations covering net revenues, scrubwear and non-scrubwear categories, U.S. and international sales, active customer measures, average order value, gross margin, operating expenses and outlook disclosures.
The company’s proxy materials address board matters, executive compensation, equity awards and annual meeting governance. Other current reports disclose material agreements, including office lease arrangements related to corporate facilities. Together, FIGS’ regulatory filings describe the business economics, capital and compensation structures, governance practices and material events of a direct-to-consumer healthcare apparel issuer.
FIGS, Inc. entered a First Amendment to its office lease to relocate and consolidate its headquarters within the building at 2834 Colorado Avenue in Santa Monica. The company will move from about 26,118 square feet of original space plus 20,033 square feet of subleased space into approximately 39,260 square feet of contiguous office space on the fourth floor, which it believes will result in overall cost savings.
The new lease term for the relocated premises is 91 months from the relocation date, with monthly base rent of $249,301 for the first 12 months and 3% annual increases up to about $306,609 in the final year. FIGS will receive a credit of base rent for the first seven months of this term if it is not in default, will surrender its original premises early without a termination fee, and will temporarily occupy the former subleased space rent-free until that surrender. The company also gains two five-year renewal options and a right of first refusal on additional space, and this arrangement creates a direct long-term lease obligation.
FIGS, Inc. reported an insider transaction by its Chief Financial Officer. On 11/04/2025, the CFO sold 22,745 Class A shares at a $7.3869 weighted average price, executed under a Rule 10b5-1 instruction to cover taxes and fees from the vesting and settlement of RSUs. Following the sale, the officer beneficially owned 845,345 shares. Of these, 732,504 are RSUs, each representing a contingent right to receive one share of Class A common stock.
FIGS, Inc. (FIGS) reported an insider transaction by Executive Chair and Director Heather Hasson. On 11/04/2025, she sold 23,356 Class A shares, a sale made pursuant to a Rule 10b5-1 instruction letter, solely to cover taxes and fees related to the vesting and settlement of RSUs.
Following the transaction, she beneficially owns 1,274,841 Class A shares directly, including 888,627 RSUs, plus 8,338 Class A shares held by the Heather Hasson Revocable Trust and 141 Class A shares held by Hollywood Capital Partners LLC. She also holds 2,814,480 Class B shares (convertible into Class A at her option) and 11,629,313 Class A shares underlying vested options. The reported sale had a weighted average price of $7.3869 per share within a disclosed range.
FIGS, Inc. reported stronger Q3 2025 performance with net revenues of $151.7 million and gross margin of 69.9%, driven by fewer discounts, improved returns processing, and lower inbound freight and duty rates, partially offset by tariffs. Net income was $8.7 million (diluted EPS $0.05), reversing a loss a year ago, as operating expenses declined with notably lower marketing spend.
Active customers rose to 2.8 million (up 4% year over year). Cash and cash equivalents were $46.5 million with $195.1 million in short-term investments. Year-to-date operating cash flow was $0.2 million, reflecting inventory builds to $151.2 million. The company amended its $100 million revolving credit facility on November 3, 2025, extending maturity to 2030 and reducing the undrawn fee. Under its repurchase program, FIGS bought back 567,607 shares for approximately $2.7 million year to date, with $52.0 million remaining authorization. Management notes current tariffs reduced Q3 gross margin by 120 bps.
FIGS, Inc. furnished an 8-K announcing financial results for the three and nine months ended September 30, 2025. The full press release is provided as Exhibit 99.1, and a financial highlights presentation was posted to the company’s investor relations site at ir.wearfigs.com/financials/quarterly-results.
The disclosures under Items 2.02 and 7.01, including Exhibit 99.1, are being furnished and not filed under the Exchange Act. FIGS’ Class A common stock trades on the NYSE under the symbol FIGS. The 8-K was signed by CFO Sarah Oughtred.
FIGS, Inc. (FIGS) reported a Form 144 notice indicating an intended sale of up to 22,745 shares of Class A common stock through E*TRADE, with an aggregate market value $168,015.2. The approximate sale date listed is 11/04/2025 on the NYSE.
The filer previously sold 99,834 shares on 08/04/2025 for $617,972.46 and 9,968 shares on 10/03/2025 for $73,364.48. The securities to be sold include shares acquired on 11/03/2025 upon vesting of 41,050 RSUs under the company’s 2021 Equity Incentive Award Plan, listed as consideration for services rendered. Shares outstanding were 154,989,563.
FIGS, Inc. received a Form 144 notice for a planned sale of 23,356 Class A common shares, with an aggregate market value of $172,528.61. The filing lists E*TRADE Financial Corporation as broker and the NYSE as the exchange, with an approximate sale date of 11/04/2025.
The shares to be sold relate to equity that was acquired on 11/03/2025 upon vesting of 59,241 restricted stock units under the issuer’s 2021 Equity Incentive Award Plan, noted as consideration for “Services Rendered.” Shares outstanding were 154,989,563.
FIGS, Inc. CFO Sarah Oughtred reported the vesting and settlement of restricted stock units that increased her beneficial holdings and the sale of a portion of shares to cover taxes. On 10/03/2025 she sold 9,968 shares of Class A common stock at $7.36 per share under a 10b5-1 instruction letter to satisfy tax and fee obligations tied to RSU vesting. After the transactions she beneficially owned 868,090 shares, of which 773,554 are RSUs representing contingent rights to receive Class A shares. The Form 4 was signed by an attorney-in-fact on 10/06/2025.
Catherine Spear, CEO and director of FIGS, Inc. (FIGS), reported the vesting and settlement of restricted stock units and an associated sell-to-cover tax sale on 10/02/2025. The filing shows 62,213 Class A shares sold at $6.8809 per share solely to satisfy tax and fee obligations under a 10b5-1 plan. After the transactions, the reporting person beneficially owns 1,907,033 Class A shares directly and indirectly, plus 5,469,161 Class B shares convertible into Class A, and 19,347,466 Class A shares underlying vested options. The report discloses that 1,339,906 of the owned securities are RSUs that vested and settled.
FIGS, Inc. insider Sarah Oughtred filed a Form 144 disclosing a proposed sale of 9,968 shares of Class A common stock with an aggregate market value of $73,364.48, expected on 10/03/2025 on the NYSE. The shares were acquired on 10/01/2025 upon vesting of Restricted Stock Units under the company's 2021 Equity Incentive Award Plan; the filing records 20,067 shares acquired in that vesting event and notes payment as services rendered.
The filing also lists a prior sale by the same person on 08/04/2025 of 99,834 shares for gross proceeds of $617,972.46. The filer certifies they are not aware of undisclosed material adverse information about the issuer. This notice is a routine compliance disclosure under Rule 144 describing recent acquisitions and proposed dispositions by an insider.